High-Throughput Cancer Cell Sphere Formation for Characterizing the Efficacy of Photo Dynamic Therapy in 3D Cell Cultures

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chen, Yu Chih ^a   Lou, Xia ^a   Zhang, Zhixiong ^a   Ingram, Patrick ^a   Yoon, Euisik ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOMATERIAL; CISPLATIN; PHOTOSENSITIZING AGENT;

APOPTOSIS; BIOLOGICAL MODEL; CELL CULTURE TECHNIQUE; CHEMISTRY; CYTOLOGY; DEVICES; DRUG EFFECTS; DRUG RESISTANCE; FIBROBLAST; HUMAN; LIGHT; METABOLISM; MICROFLUIDIC ANALYSIS; MULTICELLULAR SPHEROID; NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FIBROBLASTS; HUMANS; LIGHT; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SPHEROIDS, CELLULAR;

EID: 84936931323     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12175     Document Type: Article

References (45)

1. Moan, J. & Peng, Q. An outline of the hundred-year history of PDT. Anticancer Res. 23, 3591-3600 (2002).
2. Patrice, T. (Ed.). Photodynamic therapy (Vol. 2). Royal Society of Chemistry (2003).
3. Luksiene, Z. Photodynamic therapy: mechanism of action and ways to improve the efficiency of treatment. Medicina (Kaunas), 39, 1137-1150 (2002).
4. Nowis, D. et al. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim. Pol. 52, 339 (2005).
5. Dolmans, D. E., Fukumura, D. & Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380-387 (2003).
6. Robertson, C. A., Evans, D. H. & Abrahamse, H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J. Photochem. Photobio., B 96, 1-8 (2009).
7. Lou, X. et al. A high-throughput photodynamic therapy screening platform with on-chip control of multiple microenvironmental factors. Lab Chip 14, 892-901 (2014).
8. Yoon, H. K. et al. Nanophotosensitizers Engineered to Generate a Tunable Mix of Reactive Oxygen Species, for Optimizing Photodynamic Therapy, Using a Microfluidic Device. Chem. Mater. 26, 1592-1600 (2014).
9. Lin, R. Z. & Chang, H. Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J. 3, 1172-1184 (2008).
10. Li, C. L. et al. Survival advantages of multicellular spheroids vs. monolayers of HepG2 cells in vitro. Oncol Rep. 20, 1465-1471 (2008).
11. Neuži, P., Giselbrecht, S., Länge, K., Huang, T. J. & Manz, A. Revisiting lab-on-a-chip technology for drug discovery. Nat. Rev. Drug Discov. 11, 620-632 (2012).
12. Breslin, S. & O'Driscoll, L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov. Today 18, 240-249 (2013).
13. Torisawa, Y. S. et al. A multicellular spheroid array to realize spheroid formation, culture, and viability assay on a chip. Biomaterials 28, 559-566 (2007).
14. Tung, Y. C. et al. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 136, 473-478 (2011).
15. Hsiao, A. Y. et al. Micro-ring structures stabilize microdroplets to enable long term spheroid culture in 384 hanging drop array plates. Biomed. Microdevices 14, 313-323 (2012).
16. Sakai, Y. & Nakazawa, K. Technique for the control of spheroid diameter using microfabricated chips. Acta biomater. 3, 1033-1040 (2007).
17. Ungrin, M. D., Joshi, C., Nica, A., Bauwens, C. & Zandstra, P. W. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PloS One 3, e1565 (2008).
18. Lee, W. G., Ortmann, D., Hancock, M. J., Bae, H. & Khademhosseini, A. A hollow sphere soft lithography approach for long-term hanging drop methods. Tissue Eng. Part C: Methods 16, 249-259 (2009).
19. Tekin, H. et al. A. Stimuli-responsive microwells for formation and retrieval of cell aggregates. Lab Chip 10, 2411-2418 (2010).
20. Ota, H. et al. Three-dimensional spheroid-forming lab-on-a-chip using micro-rotational flow. Sens. Actuators B 147, 359-365 (2010).
21. Akiyama, Y. & Morishima, K. Label-free cell aggregate formation based on the magneto-Archimedes effect. Appl. Phys. Lett. 98, 163702 (2011).
22. Agarwal, P. et al. One-step microfluidic generation of pre-hatching embryo-like core-shell microcapsules for miniaturized 3D culture of pluripotent stem cells. Lab Chip 13, 4525-4533 (2013).
23. Lan, S. F. & Starly, B. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Toxicol. Appl. Pharmacol. 256, 62-72 (2011).
24. Chan, H. F. et al. Rapid formation of multicellular spheroids in double-emulsion droplets with controllable microenvironment. Sci. Rep. 3, 3462 (2013).
25. Wu, L. Y., Di Carlo, D. & Lee, L. P. Microfluidic self-assembly of tumor spheroids for anticancer drug discovery. Biomed. Microdevices 10, 197-202 (2008).
26. Toh, Y. C. et al. A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip. 7, 302-309 (2007).
27. Torisawa, Y. S. et al. Efficient formation of uniform-sized embryoid bodies using a compartmentalized microchannel device. Lab Chip 7, 770-776 (2007).
28. Hsiao, A. Y. et al. Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids. Biomaterials 30, 3020-3027 (2009).
29. Lee, K. et al. Gravity-oriented microfluidic device for uniform and massive cell spheroid formation. Biomicrofluidics 6, 014114 (2012).
30. Kuo, C. T., Chiang, C. L., Huang, R. Y. J., Lee, H. & Wo, A. M. Configurable 2D and 3D spheroid tissue cultures on bioengineered surfaces with acquisition of epithelial-mesenchymal transition characteristics. NPG Asia Materials. 4, e27 (2012).
31. Patra, B. et al. A microfluidic device for uniform-sized cell spheroids formation, culture, harvesting and flow cytometry analysis. Biomicrofluidics 7, 054114 (2013).
32. Lou, X., Yoon, H. K., Chen, Y. C., Kopelman, R. & Yoon, E. Characterization of nano-photosensitizer delivery and photodynamic efficacy using multicellular tumor spheroids (MCTS). International Conference on Miniaturized Systems for Chemistry and Life Sciences (Micro TAS' 14), 178-180, Aan Antonio, Oct., 2014.
33. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392-401 (2006).
34. Liu, D. & Hornsby, P. J. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res. 67, 3117-3126 (2007).
35. Loeffler, M., Krüger, J. A., Niethammer, A. G. & Reisfeld, R. A. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J. Clin. Invest. 116, 1955-1962 (2006).
36. Holohan, C., Van Schaeybroeck, S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13, 714-726 (2013).
37. Yang, Y. et al. Evaluation of photodynamic therapy efficiency using an in vitro three-dimensional microfluidic breast cancer tissue model. Lab Chip. 15, 735-44 (2015).
38. Re, F. et al. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. The J. Cell Biol. 127, 537-546 (1994).
39. Chen, Y. C., Ingram, P., Lou, X. & Yoon, E. Single Cell Suspension Culture Using PolyHEMA Coating for Anoikis Assay and Sphere Formation. In The 16th International Conference on Miniaturized Systems for Chemistry and Life Sciences (Micro TAS' 12), 1241-1244, Okinawa, Oct. 2012.
40. Ingram, P. N., Chen, Y. C. & Yoon, E. PolyHEMA soft lithography for selective cell seeding, migration blocking, and high-throughput suspension cell culture. International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS ' 13), 1451-1453, Freiburg, Oct. 2013.
41. Siddik, Z. H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279 (2003).
42. Kim, M. & Ma, E. Synthesis of 2-and 7-Substituted C19 Steroids Having a 1, 4, 6-Triene or 1, 4-Diene Structure and Their Cytotoxic Effects on T47D and MDA-MB231 Breast Cancer Cells. Molecules 15, 4408-4422 (2010).
43. Chow, K. et al. A gold (III) porphyrin complex with antitumor properties targets the Wnt/β -catenin pathway. Cancer Res. 70, 329-337 (2010).
44. Kobayashi, H. et al. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc. Natl. Acad. Sci. 90, 3294-3298 (1993).
45. Day, M. L. et al. E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. J. Biol. Chem. 274, 9656-9664 (1999).